MedPal AI Plc

As of February 28, 2026, MedPal AI Plc carries a market capitalization of 1.99B, placing it among publicly traded companies globally. Its enterprise value stands at 2.07B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

MedPal AI Plc's next confirmed earnings release is scheduled for October 28, 2026.

As of February 28, 2026, MedPal AI Plc has 455.15M shares outstanding.

These figures are as of February 28, 2026.

As of February 28, 2026, MedPal AI Plc maintains a current ratio of 1.04, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended February 28, 2026.

As of the close on October 22, 2026, MedPal AI Plc's stock has declined approximately 47.43% over the past 52 weeks. The 50-day moving average sits at 5.53, while the 200-day moving average is 4.16.

As of February 28, 2026, MedPal AI Plc holds 418,900.00 in cash and equivalents against 74.44M in total debt, resulting in a net debt position of 29.82M. Total book value stands at 51.50M, with working capital of 5.21M providing operational flexibility.